《盈警響號》新興光學(00125.HK)料年度盈轉虧
新興光學(00125.HK)發盈警,料截至今年3月底的年度將錄虧損,而去年同期則錄7,251.9萬元純利。期內盈轉虧主要因全球冠狀病毒爆發減低了世界各國對眼鏡產品的需求,並且延後了中國、意大利、美國及其他亞洲地區客戶的出貨安排。同時內地控制病毒傳播的措施亦影響到集團的生產及營運,而集團於內地的大部分正常營運已於3月大致回復。
另外受中美貿易糾紛、英國退歐問題及上述近期冠狀病毒爆發引致宏觀經濟環境轉差,並使業務因而變得不確定,預期集團眼鏡業務的營業額會因此大幅減少等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.